Valeant Pharmaceuticals International Business Analyst Salaries in Salinas, CA
The average Valeant Pharmaceuticals International Business Analyst in Salinas, CA earns an estimated $140,442 annually, which includes an estimated base salary of $114,525 with a $25,917 bonus. Valeant Pharmaceuticals International's Business Analyst compensation is $56,971 more than the US average for a Business Analyst. Business Analyst salaries at Valeant Pharmaceuticals International in Salinas, CA can range from $113,000 - $160,000.
In Salinas, CA, The Marketing Department at Valeant Pharmaceuticals International earns $1,445 more on average than the Design Department.
Last updated 2 years ago.
- $114,525
- avg. base
- $25,917
- avg. bonus
Business Analyst Salaries at Valeant Pharmaceuticals International
In Salinas, CA, Business Analysts earn $4,147 more than Business Analysts, and $36,934 less than Senior Marketing Managers.
Compensation at Valeant Pharmaceuticals International by Department
In Salinas, CA, The Marketing Department averages $1,445 more than the Design Department, and $5,765 less than the Sales Department
Business Analyst Compensation by Gender (All Companies)
The average female Business Analyst at companies similar size to Valeant Pharmaceuticals International reported making $89,933, while the average male Business Analyst at similar sized companies reported making $93,781.
Business Analyst Compensation by Ethnicity (All Companies)
The average Native American Business Analyst at companies similar size to Valeant Pharmaceuticals International reported making $115,000, while the average African American/Black Business Analyst at similar sized companies reported making $75,705.
How Business Analysts at Valeant Pharmaceuticals International Rate Their Compensation
The majority of Business Analysts at Valeant Pharmaceuticals International believe they're compensated fairly. The vast majority (80%) of Business Analysts at Valeant Pharmaceuticals International are satisfied with their benefits. See more compensation ratings at Valeant Pharmaceuticals International
